Southern magnesium & chemicals Limited has announced that its Board of Directors will convene on February 5, 2026, to review and approve the company's quarterly financial performance. The meeting represents a key milestone in the company's regulatory compliance and investor communication schedule.

Board Meeting Details

The board meeting has been scheduled in accordance with Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The session will take place at the company's registered office located at Deccan Chambers, 5th Floor, 6-3-666/B, Somajiguda, Hyderabad, Telangana – 500 082.

Financial Results Review

The primary agenda item for the board meeting involves the consideration and approval of the company's unaudited financial results for the quarter ended December 31, 2025. This quarterly review forms part of the company's regular financial reporting obligations to shareholders and regulatory authorities. The board will also address other agenda items during the session.

Trading Window Restrictions

In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct, Southern Magnesium and Chemicals Limited has implemented trading window restrictions. The closure period commenced on January 1, 2026, and will remain in effect until 48 hours after the financial results are announced to the stock exchange.

Corporate Communication

The formal notice was issued on January 30, 2026, from the company's Hyderabad office and communicated to BSE Limited. Company Secretary and Compliance Officer Pasupulati Manisha signed the official communication, ensuring proper regulatory disclosure procedures were followed. The company maintains its listing on BSE with scrip code 513498.

Southern magnesium & chemicals Limited has issued a clarification to BSE regarding recent movements in its share price, stating that the fluctuations are attributed to market factors rather than company-specific developments. The response was issued on January 22, 2026, following a surveillance inquiry from the stock exchange.

BSE Surveillance Inquiry Response

The company responded to BSE's email reference number L/SURV/ONL/PV/AJ/2025-2026/3300 dated January 21, 2026, which sought clarification on the price movement of the company's shares. Southern Magnesium & Chemicals emphasized its commitment to regulatory compliance and timely disclosure practices.

Regulatory Compliance Statement

The company provided comprehensive details regarding its disclosure practices:

Southern Magnesium & Chemicals confirmed that it has made all necessary prompt disclosures pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The company stated that it has not withheld any events, information, or announcements, including any price-sensitive information that may impact operations, performance, or share price behavior.

Management Response

The clarification was signed by N. Rajender Prasad, Managing Director and CFO (DIN: 00145659), who digitally signed the document on January 22, 2026. The company emphasized its consistent adherence to regulatory requirements and commitment to continue such compliance in the future.

The management concluded that the share price movement is purely due to market factors and not specifically related to any company developments. This response demonstrates the company's proactive approach to addressing exchange inquiries and maintaining transparency with stakeholders.